期刊文献+

缺血预适应通过抑制TLR4/NF-_κB信号通路保护大鼠心肌缺血再灌注损伤(英文) 被引量:7

Ischemic preconditioning protects against myocardial ischemia-reperfusion injury through inhibiting toll-like receptor 4/NF-~κB signaling pathway in rats
下载PDF
导出
摘要 目的:研究缺血预适应对大鼠心肌缺血再灌注损伤的保护作用是否由toll样受体4(TLR4)/NF-κB途径所介导,以及是否与促进降钙素基因相关肽(CGRP)释放有关。方法:结扎Sprague-Dawley大鼠左冠状动脉前降支60 min,复灌3 h造成心肌缺血再灌注损伤。缺血预适应为结扎大鼠左冠状动脉前降支5 min,复灌5 min,共4个周期。RT-PCR分析心肌TLR4 mRNA表达。免疫组织化学法分析心肌TLR4和NF-κB蛋白表达。同时,测定心肌梗死面积、血浆CGRP浓度和血清肌酸激酶活性。结果:缺血预适应显著减少心肌梗死面积,降低肌酸激酶活性,增高血浆CGRP水平。心肌缺血再灌注可显著上调TLR4和NF-κB表达,缺血预适应可抑制其作用。结论:缺血预适应通过抑制TLR4/NF-κB信号通路保护大鼠心肌缺血再灌注损伤,其作用与促进CGRP释放有关。 Objective To investigate whether the protection of ischemic preconditioning(IPC) against myocardial ischemia/reperfusion(I/R) injury is mediated by toll-like receptor 4(TLR4)/NF-κB pathway,and whether these effects are related to the release of calcitonin gene-related peptide(CGRP).Methods Sprague-Dawley rats were subjected to 60 min of ligation of the left anterior descending coronary artery followed by 3 h of reperfusion to induce I/R injury.IPC was performed by 4 cycles of 3-min left coronary artery occlusion followed by 5-min reperfusion before the I/R.The expression of TLR4 mRNA was determined by RT-PCR.TLR4 and NF-κB protein expression were analyzed by immunohistochemistry.Myocardial infarct size,CGRP concentration in plasma and activity of creatine kinase in serum were also measured.Results IPC significantly reduced the infarct size and creatine kinase activity concomitantly with the increase in plasma CGRP concentration.The expressions of TLR4 protein and mRNA and NF-κB protein were increased by myocardial I/R injury,and dramatically inhibited by IPC.Conclusion IPC protects against myocardial I/R injury by inhibition of TLR4/NF-κB pathway.These effects are related to the increased the release of CGRP.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2011年第10期972-978,共7页 Journal of Central South University :Medical Science
基金 supported by Specialized Research Fund for the Doctoral Program of Higher Education,Ministry of Education of China(20100162110058)
关键词 TOLL样受体4 缺血再灌注损伤 缺血预适应 心脏 大鼠 toll-like receptor 4 ischemia/reperfusion injury ischemic preconditioning heart rats
  • 相关文献

参考文献21

  • 1Takeda K, Kaisho T, Akira S. Toll-like receptors [ J ]. Annu Rev Immunol, 2003, 21 : 335-376.
  • 2Vallejo J G. Role of toll-like receptors in cardiovascular disea- ses [J]. Clin Sci (Lond), 2011, 121(1) :1-10.
  • 3Fang Y, Hu J. Toll-like receptor and its roles in myocardial is- chemic/reperfusion injury [ J]. Med Sci Monit, 2011, 17 (4) : RA100-109.
  • 4Li C, Kao R L, Ha T, et al. Early activation of IKKI3 during in vivo myocardial ischemia [ J ]. Am J Physiol Heart Circ Physiol, 2001, 280(3): H1264-1271.
  • 5Arslan F, de Kleijn D P, Pasterkamp G. Innate immune signa- ling in cardiac ischemia [J]. Nat Rev Cardiol, 2011, 8(5) : 292-300.
  • 6Oyama J, Blais C, Liu X, et al. Reduced myocardial ischemi- a-reperfusion injury in toll-like receptor 4-deficient mice [ J ]. Circulation, 2004, 109(6) :784-789.
  • 7Shimamoto A, Chong A J, Yada M, et al. Inhibition of Toll- like receptor 4 with eritoran attenuates myocardial ischemia/ reperfusion injury [ J ]. Circulation, 2006, 114 ( 1 Suppl ) : I270 -274.
  • 8Ha T, Liu L, Kelley J, et al. Toll-like receptors: new players in myocardial ischemia/reperfusion injury [ J~. Antioxid Redox Signal, 2011, 15(7) : 1875-1893.
  • 9Cohen M V, Downey J M. Is it time to translate ischemic pre- conditioning~ mechanism of cardioprotection into clinical prac- tice? [j~. J Cardiovasc Pharmacol Ther, 2011, 16(3/4): 273-280.
  • 10Chai W, Mehrotra S, Jan Danser A H, et al. The role of calci- tonin gene-related peptide (CGRP) in ischemic precondition- ing in isolated rat hearts [ J]. Eur J Pharmacol, 2006, 531 ( 1- 3) : 246-253.

同被引文献91

  • 1洪莉丽,张盛,汪倩,赵亚婷,朱倩,彭灿,陈卫东.基于RAAS/NF-κB/炎症因子级联反应探究真武汤对慢性心力衰竭大鼠治疗作用[J].中草药,2020,51(5):1279-1286. 被引量:41
  • 2史君,王星,赵慧辉,王伟.近20年慢性心力衰竭中医现代临床用药规律分析[J].北京中医药大学学报,2020(10):841-848. 被引量:33
  • 3中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会,杨杰孚,张健,韩雅玲.中国心力衰竭诊断和治疗指南2018[J].中华心力衰竭和心肌病杂志(中英文),2018,2(4):196-225. 被引量:823
  • 4李斌.心肌缺血预适应与急性心肌梗死预相关性研究[J].中国临床实用医学,2014(5):54-55. 被引量:4
  • 5Fei QI,Zhi-xin LIANG,Dan-yang SHE,Guang-Tao YAN,Liang-an CHEN.A Clinical Study on the Effects and Mechanism of Xuebijing Injection ( <ce:link locator="fx1"/> ) in Severe Pneumonia Patients[J].Journal of Traditional Chinese Medicine.2011(1)
  • 6胡盛寿.中国心血管病报告2013[M].北京:中国大百科全书出版社,2013:1-14.
  • 7Vincent A, Lattuca B, Merlet N, et al. New insights in research about acute ischemic myocardial injury and inflammation [ J ]. Anti-inflamm Antiallergy Agents Med Chem, 2013, 12(1) : 47-54.
  • 8Moreira DM, da Silva RL, Vieira JL, et al. Role of vascular inflammation in coronary artery disease: Po- tential of anti-inflammatory drugs in the prevention of atherothrombosis : Inflammation and anti-inflammatory drugs in coronary artery disease [ J ]. Am J Cardiovasc Drugs, 2014, 36(2) : 147-158.
  • 9Timmers L, Pasterkamp G, de Hoog VC, et al. The innate immune response in reperfused myocardium [J]. Cardiovasc Res, 2012, 94(2): 276-283.
  • 10Marchant DJ, Boyd JH, Lin DC, et al. Inflammation in myocardial diseases[ J ]. Circ Res, 2012, 110( 1 ) : 126-144.

引证文献7

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部